Related Experiment Video
Updated: Jul 8, 2026

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
Mushroom poisoning
Ivan Soldo1, Zdravko Kucan, Jasmina Timarac
1Department of Infectious Diseases, University Hospital "Osijek", Osijek, Croatia. soldo.ivan@kbo.hr
Abstract:
In the research we included a total of 207 subjects with the dismissal diagnosis of "mycetismus", who were treated at the Department of Infectious Diseases, General Hospital Osijek, during the 1983-1992 period. 32 of them were children. There were 44.93% of men, 39.61% of women and 15.45% of children. The latent time > 6 hours was determined in 51 (25%) and < 6 hours in 75% of subjects. In 156 of patients with the latent time > 6 hours, "false" poisoning occured, while 51 patients experienced real mushroom toxins poisoning. At the admission to the hospital, in patients with the latent time > 6 hours, a pathological PT (protrombine time) was established only in women, leukocytosis in both women and children, increased concentration of GGT (gamma-glutamin-transferase) in men, increased AST (aspartate-aminotransferase) and ALT (alanin-aminotransferase) only in women, and increased urea in both women and children. After 24 hours, control measuring established high values of AST and ALT extended PT uremia and exalted amount of ammonia in blood in 11 of patients (2 men, 7 women and 2 children). They had severe liver and kidney damage, the most probably caused by Amanita phalloides toxins. The latent time lasted 9 to 13 hours. Of the 11 above mentioned patients, 2 women, aged 74 and 43, and one girl, aged 6, died. No pathological laboratory parameters were established in 40 of subjects with the latent time of 6 and more hours, and the disease manifested through vomiting and diarrhea that lasted for several days. These subjects most probably suffered from mushroom toxins poisoning. Mushroom toxins irritate the mucuous membrane of the gastrointestinal tract, and there are many such poisonous mushrooms. There were no mortalities in this group of subjects.
Insights
Mushroom poisoning (mycetismus) can cause severe liver and kidney damage, especially with delayed treatment. Early symptoms like vomiting and diarrhea may indicate less severe poisoning, with no fatalities observed in such cases.
Area of Science:
- Toxicology
- Infectious Diseases
- Gastroenterology
Background:
- Mycetismus, or mushroom poisoning, presents a significant public health concern.
- Delayed diagnosis and treatment are associated with poorer outcomes.
- Understanding the clinical manifestations and laboratory findings is crucial for effective management.
Purpose of the Study:
- To analyze the clinical characteristics and outcomes of patients diagnosed with mycetismus.
- To identify risk factors and predictors of severe poisoning.
- To differentiate between true mushroom toxin poisoning and other causes of gastrointestinal distress.
Main Methods:
- Retrospective analysis of 207 patients treated for mycetismus between 1983 and 1992.
- Categorization of patients based on latent time (time from ingestion to symptom onset).
- Evaluation of clinical symptoms, laboratory parameters (PT, GGT, AST, ALT, urea), and mortality rates.
Main Results:
- 75% of patients had a latent time < 6 hours, while 25% had > 6 hours.
- Severe liver and kidney damage, likely from Amanita phalloides, was observed in 11 patients with latent times of 9-13 hours, resulting in 3 fatalities.
- 40 patients with latent time > 6 hours experienced gastrointestinal symptoms without pathological lab findings and had no mortalities.
Conclusions:
- Delayed onset of mycetismus symptoms (> 6 hours) is associated with a higher risk of severe poisoning and potential fatalities.
- Early gastrointestinal symptoms without significant laboratory abnormalities may indicate less severe mushroom toxin exposure.
- Prompt medical attention and understanding of symptom latency are critical in managing mushroom poisoning.
Related Concept Videos
Fungal Phylum Basidiomycota
Pharmaceutical Poisoning: Treatment Strategies
Pharmaceutical Poisoning: Potential Scenarios
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Prevention of Further Absorption of Poison
Fungal Group Zygomycota
